Hillenbrand (HI) completed the sale of its majority interest in the Milacron injection molding and extrusion business to Bain Capital for $287 million.
Proceeds will be used to pay down debt, Hillenbrand said Monday in a statement.
"This transaction reflects the continued transformation of Hillenbrand's portfolio mix as a pure-play industrial company," Chief Executive Officer Kim Ryan said in the statement.
Bain now own 51% of Milacron, and Hillenbrand has 49%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。